Medicinal Mushroom Resource Center

The Medicinal Mushroom Resource Center is dedicated to providing care and education to individuals about responsible psilocybin use to optimize mind-body-spirit wellness. Their mission is to provide Canadians with a safe atmosphere to talk about their interest in psilocybin micro-dosing and providing an encouraging environment to promote healthy mental health.

Microdosing, the act of consuming a sub-hallucinogenic dose of a psychedelic (usually psilocybin or LSD), has been found to result in improved mood, focus, and creativity alongside decreased symptoms of depression and anxiety. With this practice becoming increasingly popular, many are interested in exploring microdosing as an option to help manage their mental health. Frshminds got the chance to inquire more about MMCR and their motivation for psilocybin-related support and education.

Can you tell us a bit about the Medicinal Mushroom Resource Center? 

Medicinal Mushroom Resource Center is our parent company and medical clinic. Check us out at mmrc.care

MMRC is a first-of-its-kind Medicinal Psilocybin Resource Centre providing support and education in the use of psilocybin for treatment of resistant health concerns. The hub between patients, doctors, and their medicinal supply, MMRC will work with those who qualify for access to a legal source of psilocybin. Following our cannabis clinic model, MMRC will provide a clinical space for patients to meet doctors for support and aftercare alongside access to educational information, consultants, and healthcare professionals supporting the use of psilocybin.

MMRC Supports the following brands:

Think Mushrooms is a curated medicinal mushroom line with the intent to provide medicine to patients through the legal regulations set by Health Canada.

Founded on the principle of personal intent and a conscious collective, Think Mushrooms brings nature’s medicine to you. Because healthy living isn’t just about how you feed your body, it’s how you FEED YOUR MIND.

Mushroom Medic is a functional mushroom product created to help support the consumer in their health journey with a variety of directed blends. Acting as the Bridge to Mindful Healing, Mushroom Medic is a certified natural product (npn) and will be working in coordination with the Medicinal Mushroom Resource Center to provide education and support in the use of medicinal mushrooms.

Trip Stopper™ is a targeted product developed to take away the anxiety for users of psychoactive substances. A certified natural product (npn), Trip Stoppers™ proprietary blend minimizes the uncomfortable aspects of a psychoactive trip. If things get a little too intense, trust Trip Stopper™ to minimize the bad trip effects.

Trip Stopper™ can also be used as a daily supplement for its antioxidant properties and its ability to reduce anxiety. 

How did it start?

Having two decades of experience in the medicinal cannabis market, many of our cannabis patients were inquiring about psilocybin and legal access. Because of this interest, we felt that it was the perfect time to expand into this new branch of the alternative medical market. Seeing a very similar pattern as we did with the medicinal cannabis market we felt very confident that we could bring the same education experience and culture to another spirit plant medicine. 

Who are the founders of the Medicinal Mushroom Resource Center?

Terry Roycroft – CEO/Co-Founder

Terry Roycroft is the Co-Founder and CEO of the Medicinal Mushroom Resource Center. As a pioneer in the psychedelic health industry, Terry brings his extensive knowledge and background experience from the Cannabis industry to the MMRC patient network. 

Andrew Burnell-Jones – Executive Director/Co-Founder

Executive Director and Co-Founder of MMRC, Andrew Burnell-Jones runs a successful cannabis medical clinic and will transfer this knowledge to assist patients at MMRC. 

Kelsey Breure – COO

With international experience in the psychedelic industry and a background in biophysics and clinic management, Kelsey Breure is the Chief Operations Officer of MMRC. 

What got you interested in psilocybin?

From our experiences with cannabis, we understand that natural products can work as well as pharmaceutical products. The crossover was streamlined due to the synchronicity of these natural products (cannabis and psilocybin). Current research and movements in the market point to psilocybin specifically for its efficacy in the treatment of mental health and addiction issues. Driven by the interest from our current patient network, we felt creating our own line would allow us to address these issues and target specific ailments while upholding the highest medical standard in the marketplace. 

Can you tell us a bit about your manufacturing process? What are your manufacturing practices?  How do you handle product testing/purity?

Mushroom Medic and Trip Stopper are natural product certified (npn) brands and are produced in a GMP (good manufacturing practice) certified facility to meet Health Canada requirements and testing. The 60,000 sq ft pharmaceutical facility brings the highest standards of quality control and production to its manufacturing practices. This ensures the highest level of consistency for our patients and customers.

Our Think Mushroom line will be produced in a Health Canada R&D (research and development) facility for regulation 56 qualified patients. The product is tested at a Health Canada-certified laboratory for potency and sterility. 

How do you see psychedelic medicine and therapy evolving in the future? Do you see it going more of the pharmaceutical route or natural health product route?

We see psychedelic medicine evolving in two steps, the first being uses in the medical field with medicinal extractions for specific dosing and clinical trials. The second, as it has been with cannabis, being made available as a natural health product to the general public for recreational use once safety concerns and research has been done through the traditional medical pathways. In other parts of the world though, i.e. UK, Macedonia, Portugal, which have less stringent criteria for natural health products, we may see the quicker entry to the mainstream market. Legalization and Psilocybin being available to the public as a natural health product is an eventuality.

Being pioneers in this space, what have been the biggest challenges you’ve faced in bringing your product to market?

We are seeing a parallel of the cannabis market in that the optics and path are sometimes blurred because of the illegality. One of the biggest challenges will be overcoming those attitudes. Even with the cannabis market, until it became totally legal, there was resistance from many sectors of the population, primarily seniors and doctors. With the legalization of cannabis, we saw a huge acceptance from previously skeptical groups as the safety aspects were addressed through research in the medical market. MMRC aim’s to educate the public for safe and responsible use of psilocybin in order to mitigate this approach from reoccurring in the psychedelic health industry. At this current time, there are many companies looking into research efforts and the development of clinical trials to push this alternative medicine forward. It took many years for people to get on board with Cannabis, we see the acceptance level happening much quicker with Psilocybin because of the headway Cannabis paved in the government and in the general public. 

Share Frshminds Content With Your Network